Los desafíos en la continuidad de atención de personas viviendo con VIH en el Perú durante la pandemia de la COVID-19

Paredes, José Luís; Navarro, Rafaella; Cabrera, Diego M.; Diaz, Monica M.; Cordero, Fernando Alonso Mejía; Caceres, Carlos F.

doi:10.17843/rpmesp.2021.381.6471

Cited by 12 publications

(15 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Moreover, the number of patients that continued to use their medications, the number of hospitalizations, and the number of deaths were not negatively influenced by lockdown restrictions and other measures to mitigate the impact and spread of SARS-CoV-2. Similar findings were widely reported from various countries (Spain, USA, Perú, Uganda) [12][13][14][15]. This study further demonstrates the impact of COVID-19 on PLWH, and indicates that certain hospital practices may have allowed patients to continue to receive care when the overall healthcare system had been severely disrupted.…”

Section: Supply Of Antiretroviral Drugssupporting

confidence: 88%

Impact of COVID-19 on the Care of Patients With HIV Infection

Cancio-Suárez¹,

Alonso²,

Vivancos³

et al. 2023

Preprint

View full text Add to dashboard Cite

The COVID-19 pandemic and associated lockdown measures have been associated with substantial disruptions to health care services, including screening for human immunodeficiency virus (HIV) and management of people living with HIV (PLWH). Methods: Data from 3265 patients were examined in a retrospective cohort study. We compared outpatient follow-up for PLWH, the number of new patients, treatment adherence, hospitalizations, and deaths during the “pandemic period” (March 2020 to February 2021) to the “pre-pandemic period” (the equivalent timeframe in 2019) and the “post-pandemic period” (March to September 2021). Results: During the pandemic period, the number of new patients seen at the HIV clinic (116), as well as the requested viral load tests (2414), decreased significantly compared to the pre-pandemic (204 and 2831, respectively) and post-pandemic periods (146 and 2640, respectively)(p<0.01 for all the comparisons). However, across the three study periods, the number of drug refills (1385, 1330, 1411, respectively), the number of patients with undetectable viral loads (85%, 90%, 93%, respectively), and the number of hospital admissions among PLWH remained constant. Conclusions: Despite the COVID-19 pandemic impact, our findings show stability in the retention of clinical care, adherence to treatment, and viral suppression of PLWH, with no significant impact on hospitalization rates and all-cause mortality.

show abstract

Section: Supply Of Antiretroviral Drugssupporting

confidence: 88%

Impact of COVID-19 on the Care of Patients With HIV Infection

Cancio-Suárez¹,

Alonso²,

Vivancos³

et al. 2023

Preprint

View full text Add to dashboard Cite

show abstract

“…En general, los avances que se han dado para el control de esta pandemia han sido más notorios en el campo médico (Asociación Mexicana de Industrias de Investigación Farmacéutica, AC., 2021; Bouza et al, 2021;Moreno, 2019;ONUSIDA, 2021b;Paredes et al, 2021) y este control se puede continuar, si se aplican medidas de eficacia recomendadas. De acuerdo con Bouza et al, (2021), AMIIF (2021) y ONUSIDA (2021b), estos, dan a entender, que si bien, la infección por VIH ha dejado de tener efectos agudos y potencialmente mortales y tener un seguimiento médico como padecimiento crónico, es necesario que los pacientes aprendan a gestionar prudente y responsablemente el autocuidado en todas las áreas de la integridad, los ámbitos de vida, y para el desarrollo y avance vital propios.…”

Section: Panorama Actual De La Población Que Vive Con Vihunclassified

La psicología en el abordaje de las personas que viven con VIH

Pam López

2023

Revista CECIP

View full text Add to dashboard Cite

Debido a los avances médicos, actualmente, vivir con VIH, ya no amerita un padecimiento de carácter mortal, sin embargo, aún existen desafíos a nivel psicosocial. Es por eso por lo que la psicología al comprender una gran gama en el papel de la conducta y los procesos vitales del ser humano ha podido y debe de continuar en la contribución de acciones sociales hacia mejoras y avances en el abordaje hacia la población que vive con VIH, con el fin de influir en la población en general.

show abstract

“…A new, ambitious target has been described by the UNAIDS as ‘Fast‐Track’, with a 95‐95‐95 target by 2030, and it includes a major reduction in new HIV infections among specific populations and the elimination of discriminatory laws and practices in healthcare settings [13]. As services have improved in the country over time, further challenges have arisen, including the COVID‐19 pandemic which had a negative impact on an already weakened healthcare system, with a knock‐on effect on HIV services [14].…”

Section: Discusionmentioning

confidence: 99%

HIV treatment cascade in regions of Peru with the highest HIV prevalence

et al. 2022

View full text Add to dashboard Cite

Objectives To describe the HIV treatment cascade and care continuum in regions of highest HIV prevalence in Peru. Methods An observational longitudinal study was carried out in 14 tertiary hospitals in Peru. These are the main hospitals that administer antiretroviral treatment (ART) in the regions that represent approximately 95% of reports of HIV/AIDS cases in Peru in 2013. We included individuals older than 18 years newly diagnosed with HIV from 1 January 2011 to 31 December 2012. Medical records were reviewed until 2015. Results A total of 2119 people living with HIV (PLHIV) were identified in the selected health facilities (mean age = 35.26 years, 78% male). 97.25% [1845/1897; 95% confidence interval (CI): 96.4–97.9%] of the patients attended the consultation at least once during the follow‐up, but only 64.84% (885/1365; 95% CI: 62.2–67.4%) attended within a month after the diagnosis. After starting ART, 74.63% (95% CI: 71.9–77.2%) of PLHIV remained in healthcare. Regardless of the time after diagnosis, 88.40% (1837/2078; 95% CI: 86.9–89.7%) of PLHIV started ART during the observation time. However, 78.68% (95% CI: 76.8–80.4%) did so during the first post‐treatment year and only 28.88% (95% CI: 27.9–31.9%) after 1 month. After starting treatment, it was observed that 51.60% (95% CI: 49.2–54%) of PLHIV reached viral suppression during the follow‐up period. Conclusions Further analysis and improvements in the definition of indicators are required to achieve conclusive results; however, these data will give us a general understanding of the progress of Peruvian health policies in achieving the goal established by the WHO.

show abstract

Los desafíos en la continuidad de atención de personas viviendo con VIH en el Perú durante la pandemia de la COVID-19

Cited by 12 publications

References 13 publications

Impact of COVID-19 on the Care of Patients With HIV Infection

Impact of COVID-19 on the Care of Patients With HIV Infection

La psicología en el abordaje de las personas que viven con VIH

HIV treatment cascade in regions of Peru with the highest HIV prevalence

Contact Info

Product

Resources

About